Clinical Trial Update: Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy [Phase 2]

View source ↗

Summary

A multicenter Phase 2 randomized controlled trial evaluating Qideng Mingmu Capsule for diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Eye Disease
• Diabetic Retinopathy
• Retinal Disorders

Drugs mentioned

• Qideng Mingmu Capsule

Snippet

Sponsor: Chengdu University of Traditional Chinese Medicine | Conditions: Diabetic Retinopathy, Diabetic Eye Problems | Phase 2 | Status: COMPLETED